EAH Eco Animal Health Group Plc

TIDMEAH

RNS Number : 1112U

Eco Animal Health Group PLC

01 December 2021

1 December 2021

ECO Animal Health Group plc

("ECO" or the "Company") (AIM: EAH)

Board Appointment

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health market, is pleased to announce the appointment of Tracey James as a Non-Executive Director with immediate effect.

Tracey is a Chartered Accountant who has spent 26 years with Grant Thornton UK LLP, with the last 14 years as an Audit Partner. Tracey was a member of Grant Thornton's Oversight Board and also served on the Audit & Risk and Pensions Committees. She was also previously Finance Director of Karl Storz Endoscopy Canada (1999-2000). Tracey is currently a Non-Executive Director and Chair of the Audit Committee at specialist Engineering and Technology recruitment solutions business, Gattaca plc.

Tracey will join the Audit Committee of ECO.

Commenting on the appointment Andrew Jones, Chairman, said:

"I am delighted to welcome Tracey to the ECO Board. She has a strong financial background at senior level in Grant Thornton and brings with her a wealth of experience of growing businesses and AIM-listed companies."

Additional Information on the Board Appointment :

The following additional information is provided with regards to the appointment of Tracey Dawn James (née Clements), aged 58, in accordance with AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies:

Current directorships/partnerships:

Gattaca plc

Directorships/partnerships within the last five years:

Activate Learning Group (Charity)

Allenbuild Limited

Grant Thornton UK LLP

Millwood Designer Homes Limited

Modularwise Limited

Places for People Developments Limited

Places for People Group Limited

Places for People Ventures Limited

Places for People Ventures Operations Limited

Zeroc Group (2008) Limited

There are no further disclosures required to be made in respect of the appointment under AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

Contacts:

 
 
   ECO Animal Health Group plc 
   Marc Loomes (CEO) 
   Christopher Wilks (CFO)                     020 8447 6906 
 IFC Advisory 
  Graham Herring 
  Zach Cohen                                  020 3934 6630 
 Singer Capital Markets (Nominated Adviser 
  & Joint Broker) 
  Mark Taylor 
  George Tzimas                               020 7496 3000 
 Peel Hunt LLP (Joint Broker) 
  James Steel 
  Dr Christopher Golden                       020 7418 8900 
 Equity Development 
  Hannah Crowe 
  Matt Evans                                  020 7065 2692 
 

About ECO Animal Health

ECO Animal Health Group plc ("ECO" or "the Group") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAGZMFMRGKGMZM

(END) Dow Jones Newswires

December 01, 2021 02:00 ET (07:00 GMT)

Eco Animal Health (LSE:EAH)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Eco Animal Health (LSE:EAH)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024